This company listing is no longer active
InVivo Therapeutics Holdings Bilan de santé
Santé financière contrôle des critères 4/6
InVivo Therapeutics Holdings has a total shareholder equity of $8.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $9.6M and $666.0K respectively.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$8.58m |
| Fonds propres | US$8.92m |
| Total du passif | US$666.00k |
| Total des actifs | US$9.58m |
Mises à jour récentes de la santé financière
Recent updates
InVivo Therapeutics dips 24% on $9M direct and private placement offerings
Oct 07We're Not Very Worried About InVivo Therapeutics Holdings' (NASDAQ:NVIV) Cash Burn Rate
Aug 26
Is InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Invest In Growth?
May 05Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
Jan 18Analyse de la situation financière
Passif à court terme: NVIV.Q's short term assets ($9.5M) exceed its short term liabilities ($666.0K).
Passif à long terme: NVIV.Q has no long term liabilities.
Historique et analyse du ratio d'endettement
Niveau d'endettement: NVIV.Q is debt free.
Réduire la dette: NVIV.Q has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: Insufficient data to determine if NVIV.Q has enough cash runway based on its current free cash flow.
Prévisions de trésorerie: Insufficient data to determine if NVIV.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.